DERMATA THERAPEUTICS, INC. Debt Conversion, Converted Instrument, Amount
DERMATA THERAPEUTICS, INC. (DRMA) reported Debt Conversion, Converted Instrument, Amount of $2.30 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2023-02-21
- DERMATA THERAPEUTICS, INC. debt conversion, converted instrument, amount for the quarter ending 2022-03-31 was $2.30M.
- DERMATA THERAPEUTICS, INC. debt conversion, converted instrument, amount for fiscal 2022 was $2.30M, a 0.00% change from fiscal 2021.
- DERMATA THERAPEUTICS, INC. debt conversion, converted instrument, amount for fiscal 2021 was $2.30M, a 100.87% increase from fiscal 2020.
- DERMATA THERAPEUTICS, INC. debt conversion, converted instrument, amount for fiscal 2020 was $1.15M.
| Period end | Debt Conversion, Converted Instrument, Amount 1 month | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|
| 2022-12-31 | $2.30M 10-K · filed 2023-02-21 | ||
| 2022-03-31 | $2.30M 10-Q · filed 2022-05-16 | ||
| 2021-12-31 | $2.30M 10-K · filed 2022-03-28 | ||
| 2020-12-31 | $1.15M 10-K · filed 2023-02-21 | ||
| 2020-10-31 | $1.15M 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |